Formulation of keratin/HPMC matrix tablets for sustained delivery of diclofenac potassium for the management of inflammation
Résumé
Purpose: To investigate the excipient properties of keratin/HPMC in sustained-release diclofenac matrix tablets.Method: Tablets were prepared by wet granulation using different keratin/HPMC ratios. The granules were evaluated for pre-compression parameters such as flow properties, Hausner’s ratio, Carr’s index, while the matrix tablets were evaluated for post-compression parameters such as hardness, disintegration time, in-vitro drug release and release kinetics.Results: There was no significant difference (p > 0.05) in flow properties and compression characteristics in formulations containing either keratin alone or in combination with HPMC. Furthermore, formulations containing keratin/HPMC in equal proportions exhibited better sustained release profiles (p < 0.05). The FTIR spectra revealed no change in the functional groups of diclofenac potassium.Conclusion: Combination of keratin/HPMC improves the sustained release profile of diclofenac matrix tablets compared to either ingredient alone.
Citer ce document
Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)
Accès au document
Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter
Voir l'article sur le site de la revueLicence et provenance
Licence : CC BY
Notice moissonnée depuis OpenAlex le 28/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →